Notice of Change to Application Due Date and Instruction in Section IV in RFA-DA-24-007, "Avenir Award Program for Chemistry and Pharmacology of Substance Use Disorders (DP1- Clinical Trial Not Allowed)"
Notice NOT-DA-23-032 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 7, 2023 Category: Research Source Type: funding
Advancing Psychedelics Research for Treating Addiction (R01 Clinical Trial Not Allowed)
Funding Opportunity RFA-DA-24-028 from the NIH Guide for Grants and Contracts. The overarching goal of this NIDA Notice of Funding Opportunity (NOFO) is to elucidate and validate the molecular, cellular, circuitry and structural mechanisms and pathways that underly the pharmacology of psychedelic compounds for treating substance use disorders (SUDs) and related psychiatric and neurological co-morbidities. This NOFO will also support the design and synthesis of chemical probes to provide mechanistic insights on biological targets modulated by psychedelics, and on common targets/pathways in the context of SUD. Research su...
Source: NIH Funding Opportunities (Notices, PA, RFA) - May 16, 2023 Category: Research Source Type: funding
Notice Regarding the Data Management and Sharing Plan for Applications Submitted to PAR-20-299 or PAR-20-300, Translational Research in Maternal and Pediatric Pharmacology and Therapeutics
Notice NOT-HD-23-014 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - May 9, 2023 Category: Research Source Type: funding
Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional)
Funding Opportunity PAR-23-131 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to support translational and clinical research to (1) advance precision medicine in pregnant persons, lactating persons, and children through the development of novel tools, models, and other technologies that could have a direct clinical or health impact; (2) enhance the understanding of the underlying mechanisms of drug action, including the role of pediatric ontogeny and the dynamic physiological changes that occur during pregnancy and lactation; and (3) discover and develop novel ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 1, 2023 Category: Research Source Type: funding
Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R01 Clinical Trial Optional)
Funding Opportunity PAR-23-130 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to support translational and clinical research to (1) advance precision medicine in pregnant persons, lactating persons, and children through the development of novel tools, models, and other technologies that could have a direct clinical or health impact; (2) enhance the understanding of the underlying mechanisms of drug action, including the role of pediatric ontogeny and the dynamic physiological changes that occur during pregnancy and lactation; and (3) discover and develop novel ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 1, 2023 Category: Research Source Type: funding
Avenir Award Program for Chemistry and Pharmacology of Substance Use Disorders (DP1- Clinical Trial Not Allowed)
Funding Opportunity RFA-DA-24-007 from the NIH Guide for Grants and Contracts. oThe goal of this FOA is to attract outstanding early-stage investigators to the field of chemistry and pharmacology of substance used disorders. The award will support those in an early stage of their career who may lack the preliminary data required for an R01 grant, but who propose high impact research and who show promise of being tomorrow's leaders in the field. In recent years, there have been significant advances in methods and technologies for the identification of novel targets, mechanisms, and pathways of interest to substance use d...
Source: NIH Funding Opportunities (Notices, PA, RFA) - October 20, 2022 Category: Research Source Type: funding
Pediatric Clinical Pharmacology Research Career Development Award (K12 Clinical Trial Not Allowed)
Funding Opportunity RFA-HD-23-023 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) encourages applications for institutional research career development (K12) programs that support mentored research and career development experiences for scholars pursuing clinical, translational, and/or basic research in pediatric therapeutics. This program constitutes a national network of mentors and scholars, in contrast to K12 programs that are based solely at a single applicant institution.The primary purpose of this FOA is to ensure that a pipeline of diverse and highly trained workforce is ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 9, 2022 Category: Research Source Type: funding
Notice of Extension of PAR-20-300, "Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R01 Clinical Trial Optional)"
Notice NOT-HD-22-031 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 27, 2022 Category: Research Source Type: funding
Notice of Extension of PAR-20-299, "Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional)"
Notice NOT-HD-22-030 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 27, 2022 Category: Research Source Type: funding
Avenir Award Program for Chemistry and Pharmacology of Substance Use Disorders (DP1- Clinical Trial Not Allowed)
Funding Opportunity RFA-DA-23-014 from the NIH Guide for Grants and Contracts. oThe goal of this FOA is to attract outstanding early-stage investigators to the field of chemistry and pharmacology of substance used disorders. The award will support those in an early stage of their career who may lack the preliminary data required for an R01 grant, but who propose high impact research and who show promise of being tomorrow's leaders in the field. In recent years, there have been significant advances in methods and technologies for the identification of novel targets, mechanisms, and pathways of interest to substance use d...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 21, 2022 Category: Research Source Type: funding
Notice of Special Interest (NOSI): Research in the Chemistry and Pharmacology of Addictive Drugs
Notice NOT-DA-23-002 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 30, 2021 Category: Research Source Type: funding
Notice of Special Interest (NOSI): Basic Research on Fentanyl and Synthetic Fentanyl Analogs: Signaling, Neurobiology, and Pharmacology
Notice NOT-DA-21-033 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 24, 2021 Category: Research Source Type: funding
Notice of Participation of NIMH in PAR-20-300, "Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R01 Clinical Trial Optional)"
Notice NOT-MH-21-130 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 30, 2020 Category: Research Source Type: funding
Pre Solicitation Notice: Clinical Pharmacology Quality Assurance (CPQA) Program, RFP: 75N93021R00003
Notice NOT-AI-21-010 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 17, 2020 Category: Research Source Type: funding
Presolicitation Notice: Request for Proposals (RFP) 75N91021R00007 "Preclinical Pharmacokinetic and Pharmacology Evaluations of Agents Being Developed for Cancer Patients"
Notice NOT-CA-21-011 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 4, 2020 Category: Research Source Type: funding
